Efficacy of Selective RET Inhibitors in RET-Driven NSCLC and Thyroid Cancer: A Resource for Clinicians

Read expert insights on best practices for incorporating immune checkpoint inhibitor therapy for patients with NSCLC, from Clinical Care Options (CCO)

Julie R. Brahmer, MD
Program Director Jarushka Naidoo, MB BCH BAO, MHS Zofia Piotrowska, MD, MHS Released: January 23, 2023

On-demand webcast from a live satellite symposium at SITC 2022 on current use of IO therapy in lung cancer, from Clinical Care Options (CCO)

Julie R. Brahmer, MD
Program Director Jarushka Naidoo, MB BCH BAO, MHS Zofia Piotrowska, MD, MHS Physicians: maximum of 1.5 AMA PRA Category 1 Credits™ Released: January 17, 2023 Expired: January 16, 2024

Downloadable slideset from a live meeting series for endocrinologists featuring best practices for biomarker testing and the latest evidence on targeted therapies for advanced thyroid cancer, from Clinical Care Options (CCO)

Maria E Cabanillas, MD Lori J. Wirth, MD Released: January 4, 2023

Downloadable slideset from a workshop series from Clinical Care Options (CCO) on the management of NTRK and RET-altered lung and thyroid cancer

Saad A. Khan, MD Sandip P. Patel, MD Released: November 17, 2022